- Home
- LVTX vs MNDO Comparison
LVTX vs MNDO Comparison
Compare LVTX & MNDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVTX
- MNDO
- Stock Information
- Founded
- LVTX 2016
- MNDO 1995
- Country
- LVTX Netherlands
- MNDO Israel
- Employees
- LVTX N/A
- MNDO N/A
- Industry
- LVTX Biotechnology: Pharmaceutical Preparations
- MNDO EDP Services
- Sector
- LVTX Health Care
- MNDO Technology
- Exchange
- LVTX Nasdaq
- MNDO Nasdaq
- Market Cap
- LVTX 33.9M
- MNDO 29.3M
- IPO Year
- LVTX 2021
- MNDO 2000
- Fundamental
- Price
- LVTX $1.42
- MNDO $1.40
- Analyst Decision
- LVTX Hold
- MNDO
- Analyst Count
- LVTX 3
- MNDO 0
- Target Price
- LVTX $1.75
- MNDO N/A
- AVG Volume (30 Days)
- LVTX 48.5K
- MNDO 27.8K
- Earning Date
- LVTX 08-19-2025
- MNDO 08-12-2025
- Dividend Yield
- LVTX N/A
- MNDO 15.60%
- EPS Growth
- LVTX N/A
- MNDO N/A
- EPS
- LVTX N/A
- MNDO 0.17
- Revenue
- LVTX $4,990,000.00
- MNDO $20,677,000.00
- Revenue This Year
- LVTX N/A
- MNDO N/A
- Revenue Next Year
- LVTX N/A
- MNDO N/A
- P/E Ratio
- LVTX N/A
- MNDO $8.29
- Revenue Growth
- LVTX N/A
- MNDO N/A
- 52 Week Low
- LVTX $0.85
- MNDO $1.31
- 52 Week High
- LVTX $2.21
- MNDO $2.13
- Technical
- Relative Strength Index (RSI)
- LVTX 52.65
- MNDO 44.51
- Support Level
- LVTX $1.33
- MNDO $1.40
- Resistance Level
- LVTX $1.67
- MNDO $1.50
- Average True Range (ATR)
- LVTX 0.13
- MNDO 0.05
- MACD
- LVTX 0.00
- MNDO -0.00
- Stochastic Oscillator
- LVTX 25.00
- MNDO 1.92
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.